Neurologic Manifestations  >>  topiramate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
topiramate / Generic mfg.
NCT00236691: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Completed
2
188
US
topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Epilepsy, Epilepsies, Partial, Seizures
 
12/90
NCT00236860: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Completed
2
56
US
topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Epilepsy, Epilepsies, Partial, Seizures
 
02/92
NCT00236873: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Completed
2
47
US
topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Epilepsy, Epilepsies, Partial, Seizures
 
05/93
NCT00236847: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Completed
2
60
US
topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Epilepsy, Epilepsies, Partial, Seizures
 
07/93
NCT00001725: Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain

Completed
2
100
US
Dextromethorphan
National Institute of Dental and Craniofacial Research (NIDCR)
Facial Neuralgia, Pain, Trigeminal Neuralgia
 
01/02
NCT00261469: An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans

Completed
2
38
US
topiramate
Janssen-Ortho Inc., Canada
Headache
 
11/04
NCT00011804: Topiramate in the Treatment of Sciatica

Completed
2
65
US
Topiramate
National Institute of Dental and Craniofacial Research (NIDCR)
Sciatica
 
02/05
NCT00296959: Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

Terminated
2
20
Canada
topiramate (drug)
University Health Network, Toronto
Parkinson's Disease
 
03/07
TOP-DYSK, NCT01789047: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Terminated
2
42
US
Topiramate, Topamax, Placebo, sugar pill, Amantadine, Symmetrel
Rush University Medical Center, Michael J. Fox Foundation for Parkinson's Research
Idiopathic Parkinson's Disease, Drug Induced Dyskinesia
07/16
07/16

Download Options